HUTCHMED (China) (HMDCF) Minority Interest (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Minority Interest came in at $14.2 million in Q2 2026, up 10.37% year-over-year from $12.9 million in Q2 2025, and up 6.42% quarter-over-quarter from $13.3 million in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Minority Interest (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Minority Interest for 12 consecutive years, with $14.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Minority Interest rose 10.37% year-over-year to $14.2 million in Q2 2026; TTM through Jun 2026 was $14.2 million, a 10.37% increase from a year earlier, with the FY2025 full-year figure at $13.3 million, changed N/A from the prior year.
- Minority Interest was $14.2 million for Q2 2026 at HUTCHMED (China), up from $13.3 million in the prior quarter.
- Over five years, Minority Interest peaked at $52.1 million in Q2 2022 and troughed at $11.9 million in Q2 2024.
- A 5-year average of $21.3 million and a median of $14.2 million in 2026 frame the typical range for Minority Interest.
- Across the five-year window, Minority Interest jumped 80.35% in 2022 and slumped 65.51% in 2023, its largest moves.
- Over 5 years, Minority Interest stood at $26.5 million in 2022, then slumped by 32.17% to $18.0 million in 2023, then sank by 33.62% to $11.9 million in 2024, then gained by 11.75% to $13.3 million in 2025, then advanced by 6.42% to $14.2 million in 2026.
- The last three Minority Interest figures came in at $14.2 million (Q2 2026), $13.3 million (Q4 2025), and $12.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.19 Mn |
| Dec 31, 2025 | 13.34 Mn |
| Jun 30, 2025 | 12.86 Mn |
| Jun 30, 2024 | 11.93 Mn |
| Jun 30, 2023 | 17.98 Mn |
| Dec 31, 2022 | 26.50 Mn |
| Jun 30, 2022 | 52.12 Mn |
| Dec 31, 2021 | 52.62 Mn |
| Jun 30, 2021 | 28.90 Mn |
| Mar 31, 2021 | 36.12 Mn |
| Dec 31, 2020 | 34.83 Mn |
| Jun 30, 2020 | 24.93 Mn |
| Dec 31, 2019 | 24.89 Mn |
| Sep 30, 2019 | 24.27 Mn |
| Jun 30, 2019 | 25.15 Mn |
| Mar 31, 2019 | 24.59 Mn |
| Dec 31, 2018 | 23.26 Mn |
| Jun 30, 2018 | 26.11 Mn |
| Dec 31, 2017 | 23.23 Mn |
| Jun 30, 2017 | 22.12 Mn |